Filing Details
- Accession Number:
- 0001179110-13-015758
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-10-25 17:36:26
- Reporting Period:
- 2013-10-23
- Filing Date:
- 2013-10-25
- Accepted Time:
- 2013-10-25 17:36:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1113481 | Medicines Co | MDCO | Pharmaceutical Preparations (2834) | 043324394 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1427141 | Bernard William O'connor | 8 Sylvan Way Parsippany NJ 07054 | Sr Vp & Chief Acct. Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-10-23 | 2,187 | $7.31 | 27,245 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-10-23 | 2,187 | $35.00 | 25,058 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-10-23 | 4,167 | $17.45 | 29,225 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-10-23 | 4,167 | $35.00 | 25,058 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option (Right-to-Buy) | Disposition | 2013-10-23 | 2,187 | $0.00 | 2,187 | $7.31 |
Common Stock | Option (Right-to-Buy) | Disposition | 2013-10-23 | 4,167 | $0.00 | 4,167 | $17.45 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,188 | 2020-02-19 | No | 4 | M | Direct | |
12,499 | 2021-02-18 | No | 4 | M | Direct |
Footnotes
- The common stock sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 program adopted by Mr. O'Connor on March 15, 2013.
- The option vests in 48 equal monthly installments, which commenced March 19, 2010. After the exercise of the options reported hereby, of the original grant (17,500 shares granted on February 19, 2010), 730 shares covered by this option are vested but not exercised and 1,458 shares covered by this option are unvested.
- The option vests in 48 equal monthly installments, which commenced March 18, 2011. After the exercise of the option reported hereby, of the original grant (33,333 shares granted on February 18, 2011), 1,388 shares covered by this option are vested but not exercised and 11,111 shares covered by this option are unvested.